Clinical Trial Update: Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing NovoLog (insulin aspart) and Humalog (insulin lispro) in insulin pumps for children and adolescents with Type 1 diabetes completed, as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED